Skip to main content

Table 1 Characteristics of the studies included in the review

From: The effect of therapies on the quality of life of patients with systemic lupus erythematosus: a meta-analysis of randomized trials

Author yearPopulationInterventionFollow-upOutcomeResult
Abrahão, 2015 [6]42Intervention (n = 21)
cardiovascular training
Control group (n = 21)
(usual care and information about the disease)
03 monthsQuality of lifeThe intervention group presented a significant improvement in the physical health and vitality aspect, in the general health aspect no significant differences were found (SF36 health survey questionnaire)
Arriens, 2015 [9]32Intervention (n = 18)
(supplementation with fish oil)
Control group (n = 14)
(placebo)
06 monthsQuality of lifeThe intervention group presented a significant improvement in the mental health and vitality aspect (SF36 health survey questionnaire)
Boström, 2016 [7]31Intervention (n = 17)
(physical activity)
Control group (n = 14)
(usual care)
12 monthsQuality of lifeThe intervention group had improved mental health, there was no significant improvement in the general health aspect (SF36 health survey questionnaire).
Navarrete, 2010 [4]45Intervention (n = 21)
(cognitive behavioral therapy)
Control group (n = 24)
(health care, moderate exercise, balanced diet and plenty of rest)
15 monthsQuality of lifeThe intervention group had a significant reduction in the level of depression, anxiety and daily stress and a significant improvement in QoL and somatic symptoms (SF36 health survey questionnaire).
Navarrete et al, 2010 [8]34Intervention (n = 18)
cognitive behavioral therapy
Control group (n = 16)
(usual care)
15 monthsQuality of lifeThe intervention group presented improvement in the level of physical function, vitality, general health perception andmental health (SF36 health survey questionnaire).
Shamehki, 2017 [5]68Intervention (n = 32)
(supplementation of green tea extract)
Control group (n = 36)
(placebo)
03 monthsQuality of lifeThe intervention group presented a significant increase in hrvitality and general health (SF36 health survey questionnaire).
Strand, 2013 [10]48Intervention (n = 11)
(epratuzumab 720 mg/m2)
Control group (n = 37)
(placebo)
12 monthsQuality of lifeThe intervention group showed evident improvements in the mean SF-36 scores (SF36 health survey questionnaire).